You can buy or sell BLPH and other stocks, options, ETFs, and crypto commission-free!
Bellerophon Therapeutics, Inc. Common Stock, also called Bellerophon Therapeutics, is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Read More The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.
Warren, New Jersey
52 Week High
52 Week Low
Simply Wall StMar 8
Did Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Insiders Buy Up More Shares?
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So we’ll take a look at whether insiders have been buying or selling shares in Bellerophon Therapeutics, Inc. (NASDAQ:BLPH). Do Insider Transactions Matter? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries requi...
-$0.13 per share
-$0.08 per share